화학공학소재연구정보센터
검색결과 : 3건
No. Article
1 Erythropoietin and long-acting erythropoiesis stimulating agent ameliorate non-alcoholic fatty liver disease by increasing lipolysis and decreasing lipogenesis via EPOR/STAT pathway
Tsuma Y, Mori J, Ota T, Kawabe Y, Morimoto H, Fukuhara S, Kodo K, Umemura A, Nakajima H, Hosoi H
Biochemical and Biophysical Research Communications, 509(1), 306, 2019
2 Cloning and expression of codon-optimized recombinant darbepoetin alfa in Leishmania tarentolae T7-TR
Kianmehr A, Golavar R, Rouintan M, Mahrooz A, Fard-Esfahani P, Oladnabi M, Khajeniazi S, Mostafavi SS, Omidinia E
Protein Expression and Purification, 118, 120, 2016
3 Randomized Controlled Trial of Darbepoetin alpha Versus Continuous Erythropoietin Receptor Activator Injected Subcutaneously Once Every Four Weeks in Patients with Chronic Kidney Disease at the Pre-Dialysis Stage
Furukawa T, Okada K, Abe M, Tei R, Oikawa O, Maruyama N, Maruyama T
International Journal of Molecular Sciences, 16(12), 30181, 2015